Cardioprotective Effects of Melatonin in Reperfusion Injury

[Article in English, Portuguese]

Affiliations

Editorial

[Article in English, Portuguese]

Francisco R M Laurindo. Arq Bras Cardiol. 2018 Jan.

. 2018 Jan;110(1):5-6.

doi: 10.5935/abc.20180011.

¹ Laboratório de Biologia Vascular - Instituto do Coração (InCor) - Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brazil.

No abstract available

Comment on

Melatonin-Induced Protective Effects on Cardiomyocytes Against Reperfusion Injury Partly Through Modulation of IP3R and SERCA2a Via Activation of ERK1.
Hu S, Zhu P, Zhou H, Zhang Y, Chen Y. Hu S, et al. Arq Bras Cardiol. 2018 Jan;110(1):44-51. doi: 10.5935/abc.20180008. Arq Bras Cardiol. 2018. PMID: 29538523 Free PMC article.

1. Lefer DJ, Marbán E. Is cardioprotection dead? Circulation. 2017;136(1):98–109. doi: 10.1161/CIRCULATIONAHA.116.027039. - DOI - PMC - PubMed
1. Lefer DJ, Bolli R. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. J Cardiovasc Pharmacol Ther. 2011;16(3-4):332–339. doi: 10.1177/1074248411414155. - DOI - PubMed
1. Shin B, Cowan DB, Emani SM, Del Nido PJ, McCully JD. Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury. Adv Exp Med Biol. 2017;982:595–619. doi: 10.1007/978-3-319-55330-6_31. - DOI - PubMed
1. Dietl A, Maack C. Targeting mitochondrial calcium handling and reactive oxygen species in heart failure. Curr Heart Fail Rep. 2017;14(4):338–349. doi: 10.1007/s11897-017-0347-7. - DOI - PubMed
1. Christoph M, Ibrahim K, Hesse K, Augstein A, Schmeisser A, Braun-Dullaeus RC, et al. Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- mice. Atherosclerosis. 2014;233(2):641–647. doi: 10.1016/j.atherosclerosis.2014.01.048. - DOI - PubMed